According to Psychemedics's latest financial reports the company's current EPS (TTM) is -$0.34. In 2022 the company made an earnings per share (EPS) of -$0.19 a decrease over its 2021 EPS that were of -$0.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.34 | 78.49% |
2022 | -$0.19 | 46.97% |
2021 | -$0.13 | -81.37% |
2020 | -$0.70 | -349.57% |
2019 | $0.28 | -66.42% |
2018 | $0.83 | -25.48% |
2017 | $1.12 | -8.97% |
2016 | $1.23 | 338.57% |
2015 | $0.28 | -53.33% |
2014 | $0.60 | -16.67% |
2013 | $0.72 | 26.32% |
2012 | $0.57 | -14.93% |
2011 | $0.67 | 31.37% |
2010 | $0.51 | 75.86% |
2009 | $0.29 | -49.12% |
2008 | $0.57 | -33.72% |
2007 | $0.86 | -9.47% |
2006 | $0.95 | 21.79% |
2005 | $0.78 | 41.82% |
2004 | $0.55 | 129.17% |
2003 | $0.24 | -61.9% |
2002 | $0.63 | 687.5% |
2001 | $0.08000 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Quest Diagnostics
DGX | $6.76 | -2,081.79% | ๐บ๐ธ USA |
LabCorp LH | $7.52 | -2,304.60% | ๐บ๐ธ USA |
RadNet RDNT | -$0.23 | -32.57% | ๐บ๐ธ USA |
NeoGenomics
NEO | -$0.92 | 169.71% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$0.94 | 175.57% | ๐บ๐ธ USA |